Active 0 6 0 6 O
UTI 7 10 7 10 B-chronic_disease

Allergy 0 7 11 18 O
to 8 10 19 21 O
topical 11 18 22 29 B-allergy_name
steroid 19 26 30 37 I-allergy_name

Biopsy 0 6 38 44 B-treatment
proven 7 13 45 51 O
symptomatic 14 25 52 63 O
vulvar 26 32 64 70 O
lichen 33 39 71 77 B-chronic_disease
sclerosus 40 49 78 87 I-chronic_disease

Current 0 7 88 95 O
or 8 10 96 98 O
prior 11 16 99 104 O
diagnosis 17 26 105 114 O
of 27 29 115 117 O
any 30 33 118 121 O
gynecologic 34 45 122 133 B-cancer
malignancy 46 56 134 144 I-cancer

English 0 7 145 152 B-language_fluency
Speaking 8 16 153 161 I-language_fluency

History 0 7 162 169 O
of 8 10 170 172 O
transvaginal 11 23 173 185 B-treatment
mesh 24 28 186 190 I-treatment
implant 29 36 191 198 I-treatment

Known 0 5 199 204 O
vulvar 6 12 205 211 B-cancer
malignancy 13 23 212 222 I-cancer

Pelvic 0 6 223 229 B-clinical_variable
organ 7 12 230 235 I-clinical_variable
prolapse 13 21 236 244 I-clinical_variable
> 22 23 245 246 O
than 24 28 247 251 O
Stage 29 34 252 257 B-lower_bound
2 35 36 258 259 I-lower_bound

Pregnancy 0 9 260 269 B-pregnancy

Previous 0 8 270 278 B-treatment
pelvic 9 15 279 285 I-treatment
radiation 16 25 286 295 I-treatment
therapy 26 33 296 303 I-treatment

Skindex-29 0 10 304 314 B-clinical_variable
overall 11 18 315 322 I-clinical_variable
score 19 24 323 328 I-clinical_variable
< 25 26 329 330 O
21 26 28 330 332 B-upper_bound
, 28 29 332 333 O
below 30 35 334 339 O
mildly 36 42 340 346 O
impaired 43 51 347 355 O
health 52 58 356 362 O
related 59 66 363 370 O
quality 67 74 371 378 O
of 75 77 379 381 O
life 78 82 382 386 O
threshold 83 92 387 396 O

Treatment 0 9 397 406 O
with 10 14 407 411 O
systemic 15 23 412 420 B-treatment
immunomodulators 24 40 421 437 I-treatment

excluding 0 9 438 447 O
sling 10 15 448 453 O
or 16 18 454 456 O
sacrocolpopexy 19 33 457 471 B-treatment
mesh 34 38 472 476 O

less 0 4 477 481 O
than 5 9 482 486 O
3 10 11 487 488 B-upper_bound
months 12 18 489 495 I-upper_bound
postpartum 19 29 496 506 B-chronic_disease

planning 0 8 507 515 B-pregnancy
pregnancy 9 18 516 525 I-pregnancy

topical 0 7 526 533 B-treatment
calcineurin 8 19 534 545 I-treatment
inhibitors 20 30 546 556 I-treatment
( 31 32 557 558 O
tacrolimus 32 42 558 568 B-treatment
, 42 43 568 569 O
pimecrolimus 44 56 570 582 B-treatment
) 56 57 582 583 O

vaginal 0 7 584 591 B-treatment
hormonal 8 16 592 600 I-treatment
or 17 19 601 603 O
vulvar 20 26 604 610 B-treatment
topical 27 34 611 618 I-treatment
steroid 35 42 619 626 I-treatment
use 43 46 627 630 O
within 47 53 631 637 O
2 54 55 638 639 B-upper_bound
months 56 62 640 646 I-upper_bound
of 63 65 647 649 O
enrollment 66 76 650 660 O

vulvar 0 6 661 667 B-chronic_disease
infection 7 16 668 677 I-chronic_disease
( 17 18 678 679 O
candida 18 25 679 686 B-chronic_disease
, 25 26 686 687 O
herpes 27 33 688 694 B-chronic_disease
, 33 34 694 695 O
bacterial 35 44 696 705 B-chronic_disease
vaginosis 45 54 706 715 I-chronic_disease
, 54 55 715 716 O
trichomoniasis 56 70 717 731 B-chronic_disease
or 71 73 732 734 O
other 74 79 735 740 O
infection 80 89 741 750 O
) 89 90 750 751 O

